Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · The Lancet · 320 citations
https://doi.org/10.1016/s0140-6736(22)01109-6
S
Sam Charlton
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
0
Citations
0
h-index
0
i10-index
Sam Charlton is an academic researcher. The author has contributed to research in topics: Sepsis Diagnosis and Treatment & Telemedicine and Telehealth Implementation & Mobile Health and mHealth Applications.
Papers by this author
worksEffect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021 · JAMA · 209 citations
https://doi.org/10.1001/jama.2021.18178
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022 · JAMA · 149 citations
https://doi.org/10.1001/jama.2022.2910
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat